As of the latest SEC filings, Dermata Therapeutics, Inc. (DRMA) is held by 6 institutional funds. The largest fund shareholder is Avantis Emerging Markets Equity ETF (AVEM), holding an estimated $53,787.88 in market value, representing a significant portion of its portfolio.
Funds holding Dermata Therapeutics, Inc. (DRMA)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DRMA
- CIK:
- 0001853816
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
AVEM
Avantis Emerging Markets Equity ETF
|
ETF | American Century | 0.00% | $53,787.88 | 843,000 | Feb 28, 2026 | Apr 29, 2026 |
|
AVES
Avantis Emerging Markets Value ETF
|
ETF | American Century | 0.00% | $29,892.79 | 468,500 | Feb 28, 2026 | Apr 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $25,848.00 | 21,540 | Feb 28, 2026 | Apr 24, 2026 |
|
AVEEX
Avantis Emerging Markets Equity Fund
|
MF | American Century | 0.00% | $17,884.63 | 280,300 | Feb 28, 2026 | Apr 29, 2026 |
|
AVSE
Avantis Responsible Emerging Markets Equity ETF
|
ETF | American Century | 0.00% | $8,064.99 | 126,400 | Feb 28, 2026 | Apr 29, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,327.20 | 1,106 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)